Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Current Assets (2019 - 2020)

Goldenwell Biotech filings provide 2 years of Current Assets readings, the most recent being $250544.0 for Q3 2020.

  • On a quarterly basis, Current Assets changed N/A to $250544.0 in Q3 2020 year-over-year; TTM through Sep 2020 was $250544.0, a N/A change, with the full-year FY2019 number at $246593.0, changed N/A from a year prior.
  • Current Assets hit $250544.0 in Q3 2020 for Goldenwell Biotech, up from $246593.0 in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $250544.0 in Q3 2020 to a low of $246593.0 in Q4 2019.